Antibiotic Therapy in Viral Airway Infections
Key facts
- Who runs it
- University Hospital, Akershus
- Where
- Norway12 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 380 people, planned
- Started
- 13 Jan 2022
- Expected to end
- Nov 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Stop antibiotic therapy
- Record updated
- 12 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Hospitalized
- Adults 18 year or older
- Moderately severe disease (CRB65 ≤ 2 at time of inclusion)
- Nasopharyngeal swab positive for influenza virus, parainfluenza virus, respiratory syncytial virus (RSV) or human metapneumovirus (hMPV)
- On antibiotic therapy as instituted by the receiving physician from the emergency department
- Signed informed consent must be obtained and documented according to ICH GCP, and national/local regulations
Who cannot take part
- Requiring high-flow oxygen therapy or non-invasive ventilation at screening
- Not immunocompetent (i.e. on active chemotherapy, corticosteroid therapy equaling ≥ 20 mg prednisolone daily for ≥ 4 weeks, chronic immunosuppression due to solid organ transplant)
- Time from initiation of antibiotic therapy to screening >48 hours
- Any other infection necessitating antibiotic treatment
- Antibiotic use for assumed airway infection within the last 24 hours before admission to hospital
- Requiring ICU admission at screening
- Signs of severe pneumonia (abscesses, massive pleural effusion, a well-defined lobar infiltrate on chest X-ray strongly suggestive of bacterial etiology)
- SARS-CoV-2 positive
- Bacteremia
- Urine antigen test positive for legionella
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Antimicrobial resistance is one of the most urgent health threats of our time, and Norwegian hospitals were required to reduce the use of broad-spectrum antibiotics with 30% by the end of 2020. In the current proposal, the investigators aim to assess the efficacy and safety of early discontinuation of antibiotic therapy in adult patients infected with respiratory viruses.
Read full original descriptionShow less
A general recommendation to treat all instances of community acquired pneumonia (CAP) patients with antibiotics leads to significant antibiotic overtreatment. In 2008, the US Food and Drug Administration approved the first multiplex polymerase chain reaction assay for the detection of multiple respiratory virus nucleic acids simultaneously. The wide availability of such nucleic acid amplification tests (NAAT) for rapid viral detection together with chest radiographs has the potential to define patients who can be managed without antibiotics.
Akershus University Hospital is one of the largest hospitals in Norway, with a catchment area of more than 550,000 people. In 2012 to 2013, the majority of patients admitted to Akershus University Hospital with suspected CAP and a positive viral NAAT were treated with antibiotics, a prescription pattern representing antibiotic overtreatment. The investigators accordingly hypothesize that discontinuation of antibiotic therapy in patients with moderately severe disease and airway sample positive for respiratory viruses is safe and non-inferior to continuation of antibiotic therapy.
The 2 groups in the trial
- InterventionTreatment being tested
Stop antibiotic therapy as instituted by admitting physician
Treatment: Stop antibiotic therapy
- ControlNo study treatment, for comparison
Continue antibiotic therapy at the discretion of the treating physician (no change in ongoing treatment)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Antibiotic Therapy in Viral Airway Infections: An Open Labeled Randomized Controlled Pragmatic Trial to Evaluate the Efficacy and Safety of Discontinuing Antibiotic Therapy in Adult Patients With Respiratory Viruses
- Publications
- Record updated
- 12 August 2025